Comparative Study
. 2003 Feb 1;53(3):265-7; author reply 267-8.
doi: 10.1016/s0006-3223(02)01790-0.
Atypical antipsychotic drugs improve cognition in schizophrenia
- PMID: 12559661
- DOI: 10.1016/s0006-3223(02)01790-0
Item in Clipboard
Comparative Study
Atypical antipsychotic drugs improve cognition in schizophrenia
Biol Psychiatry.
.
No abstract available
Comment on
-
The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.Biol Psychiatry. 2002 Jun 15;51(12):972-8. doi: 10.1016/s0006-3223(02)01370-7. Biol Psychiatry. 2002. PMID: 12062881 Clinical Trial.
Similar articles
-
Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.Can J Psychiatry. 1997 Nov;42(9):983. doi: 10.1177/070674379704200919. Can J Psychiatry. 1997. PMID: 9429073 Clinical Trial. No abstract available.
-
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.Arch Gen Psychiatry. 2000 Mar;57(3):249-58. doi: 10.1001/archpsyc.57.3.249. Arch Gen Psychiatry. 2000. PMID: 10711911 Clinical Trial.
-
Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.Arch Gen Psychiatry. 2002 Jun;59(6):572-3; author reply 573-5. doi: 10.1001/archpsyc.59.6.572. Arch Gen Psychiatry. 2002. PMID: 12044210 No abstract available.
-
Risperidone: efficacy and safety.Schizophr Bull. 1995;21(4):593-606. doi: 10.1093/schbul/21.4.593. Schizophr Bull. 1995. PMID: 8749887 Review.
-
Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.J Clin Psychiatry. 1998;59 Suppl 12:35-40. J Clin Psychiatry. 1998. PMID: 9766618 Review.
Cited by
-
Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models.Front Neurosci. 2020 Jun 3;14:542. doi: 10.3389/fnins.2020.00542. eCollection 2020. Front Neurosci. 2020. PMID: 32655348 Free PMC article. Review.
-
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.PLoS One. 2013;8(1):e54080. doi: 10.1371/journal.pone.0054080. Epub 2013 Jan 17. PLoS One. 2013. PMID: 23349791 Free PMC article.
-
Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD013425. doi: 10.1002/14651858.CD013425.pub2. Cochrane Database Syst Rev. 2024. PMID: 38958149 Free PMC article.
-
Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.Psychopharmacology (Berl). 2004 Jun;174(1):111-25. doi: 10.1007/s00213-003-1710-9. Epub 2004 Jan 20. Psychopharmacology (Berl). 2004. PMID: 15205882 Review.
-
Electrophysiological Evidence in Schizophrenia in Relation to Treatment Response.Front Psychiatry. 2018 Jun 13;9:259. doi: 10.3389/fpsyt.2018.00259. eCollection 2018. Front Psychiatry. 2018. PMID: 29951008 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
